Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient's undergoing urologic oncology surgery: a systematic review.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 24 04 2020
accepted: 02 07 2020
pubmed: 11 7 2020
medline: 9 6 2022
entrez: 11 7 2020
Statut: ppublish

Résumé

Enhanced recovery after surgery (ERAS) protocols have been implemented across a variety of disciplines to improve outcomes. Herein we describe the impact of ERAS on quality of life (QOL) and cost for patients undergoing urologic oncology surgery. A systematic literature search using the MEDLINE, Scopus, Clinictrials.gov, and Cochrane Review databases for studies published between 1946 and 2020 was conducted. Articles were reviewed and assigned a risk of bias by two authors and were included if they addressed ERAS and either QOL or cost-effectiveness for patients undergoing urologic oncology surgery. The literature search yielded a total of 682 studies after removing duplicates, of which 10 (1.5%) were included in the review. Nine articles addressed radical cystectomy, while one addressed ERAS and QOL for laparoscopic nephrectomy. Six publications assessed the impact of ERAS on QOL domains. Questionnaires used for assessment of QOL varied across studies, and timing of administration was heterogeneous. Overall, ERAS improved patient QOL during early phases of recovery within the realms of bowel function, physical/social/cognitive functioning, sleep and pain control. Costs were assessed in 4 retrospective studies including 3 conducted in the United States and one from China all addressing radical cystectomy. Studies demonstrated either decreased costs associated with ERAS as a result of decreased length of stay or no change in cost based on ERAS implementation. While limited studies are published on the subject, ERAS implementation for radical cystectomy and laparoscopic nephrectomy improved patient-reported QOL during early phases of recovery. For radical cystectomy, there was a decreased or neutral overall financial cost associated with ERAS. Further studies assessing QOL and cost-effectiveness over the entire global period of care in a variety of urologic oncology surgeries are warranted.

Identifiants

pubmed: 32648071
doi: 10.1007/s00345-020-03341-6
pii: 10.1007/s00345-020-03341-6
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1325-1342

Subventions

Organisme : U.S. Department of Defense
ID : W81XWH1710576

Informations de copyright

© 2020. Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Kehlet H (1997) Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth 78:606–617
pubmed: 9175983 doi: 10.1093/bja/78.5.606
Cerantola Y, Valerio M, Persson B, Jichlinski P, Ljungqvist O, Hubner M et al (2013) Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery ERAS society recommendations. Clin Nutr 32:879–887
pubmed: 24189391 doi: 10.1016/j.clnu.2013.09.014
Williams SB, Cumberbatch MG, Kamat AM, Jubber I, Kerr PS, McGrath J, et al. Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery after Surgery (ERAS) Protocols: A Systematic Review and Individual Patient Data Meta-analysis European Urology. 2020; In Press
Patel HRH, Cerantola Y, Valerio M, Persson B, Jichlinski P, Ljungqvist O et al (2014) Enhanced Recovery After Surgery: are we ready, and can we afford not to implement these pathways for patients undergoing radical cystectomy? Eur Urol 65:263–266
pubmed: 24183418 doi: 10.1016/j.eururo.2013.10.011
Moschini M, Simone G, Stenzl A, Gill IS, Catto J (2016) Critical review of outcomes from radical cystectomy: can complications from radical cystectomy be reduced by surgical volume and robotic surgery? Eur Urol Focus. 2:19–29
pubmed: 28723446 doi: 10.1016/j.euf.2016.03.001
Tyson MD, Chang SS (2016) Enhanced recovery pathways versus standard care after cystectomy: a meta-analysis of the effect on perioperative outcomes. Eur Urol 70:995–1003
pubmed: 27297680 pmcid: 5149115 doi: 10.1016/j.eururo.2016.05.031
Porter ME (2009) A strategy for health care reform–toward a value-based system. N Engl J Med 361:109–112
pubmed: 19494209 doi: 10.1056/NEJMp0904131
Elias KM, Stone AB, McGinigle K, Tankou JAI, Scott MJ, Fawcett WJ et al (2019) The reporting on ERAS compliance, outcomes, and elements research (RECOvER) checklist: a joint statement by the ERAS
pubmed: 30116862 doi: 10.1007/s00268-018-4753-0
Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52:377
pubmed: 9764259 pmcid: 1756728 doi: 10.1136/jech.52.6.377
Trac MH, McArthur E, Jandoc R, Dixon SN, Nash DM, Hackam DG et al (2016) Macrolide antibiotics and the risk of ventricular arrhythmia in older adults. Can Med Assoc J 188:E120
doi: 10.1503/cmaj.150901
Frees SK, Aning J, Black P, Struss W, Bell R, Chavez-Munoz C et al (2018) A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer. World J Urol 36:215–220
pubmed: 29116394 doi: 10.1007/s00345-017-2109-2
Karl A, Buchner A, Becker A, Staehler M, Seitz M, Khoder W et al (2014) A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a Prospective Randomized Study. J Urol. 191:335–340
pubmed: 23968966 doi: 10.1016/j.juro.2013.08.019
Jensen BT, Jensen JB, Laustsen S, Petersen AK, Søndergaard I, Borre M (2014) Multidisciplinary rehabilitation can impact on health-related quality of life outcome in radical cystectomy: secondary reported outcome of a randomized controlled trial. J Multidiscip Healthc. 7:301–311
pubmed: 25075194 pmcid: 4106955 doi: 10.2147/JMDH.S62172
Recart A, Duchene D, White PF, Thomas T, Johnson DB, Cadeddu JA (2005) Efficacy and safety of fast-track recovery strategy for patients undergoing laparoscopic nephrectomy. J Endourol 19:1165–1169
pubmed: 16359206 doi: 10.1089/end.2005.19.1165
Kukreja JB, Shi Q, Chang CM, Seif MA, Sterling BM, Chen T-Y et al (2018) Patient-reported outcomes are associated with enhanced recovery status in patients with bladder cancer undergoing radical cystectomy. Surg Innovation. 25:242–250
doi: 10.1177/1553350618764218
Zhang H, Wang H, Zhu M, Xu Z, Shen Y, Zhu Y et al (2020) Implementation of enhanced recovery after surgery in patients undergoing radical cystectomy: a retrospective cohort study. Eur J Surg Oncol 46:202–208
pubmed: 31439358 doi: 10.1016/j.ejso.2019.07.021
Chipollini J, Tang DH, Hussein K, Patel SY, Garcia-Getting RE, Pow-Sang JM et al (2017) Does implementing an enhanced recovery after surgery protocol increase hospital charges? comparisons from a radical cystectomy program at a specialty cancer center. Urology. 105:108–112
pubmed: 28342928 doi: 10.1016/j.urology.2017.03.023
Nabhani J, Ahmadi H, Schuckman AK, Cai J, Miranda G, Djaladat H et al (2016) Cost analysis of the enhanced recovery after surgery protocol in patients undergoing radical cystectomy for bladder cancer. Eur Urol Focus. 2:92–96
pubmed: 28723457 doi: 10.1016/j.euf.2015.06.009
Wei C, Wan F, Zhao H, Ma J, Gao Z, Lin C (2018) Application of enhanced recovery after surgery in patients undergoing radical cystectomy. J Int Med Res 46:5011–5018
pubmed: 30088432 pmcid: 6300971 doi: 10.1177/0300060518789035
Semerjian A, Milbar N, Kates M, Gorin MA, Patel HD, Chalfin HJ et al (2018) Hospital charges and length of stay following radical cystectomy in the enhanced recovery after surgery era. Urology. 111:86–91
pubmed: 29032237 doi: 10.1016/j.urology.2017.09.010
Myles PS, Weitkamp B, Jones K, Melick J, Hensen S (2000) Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth 84:11–15
pubmed: 10740540 doi: 10.1093/oxfordjournals.bja.a013366
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI J Natl Cancer Inst. 85:365–376
pubmed: 8433390 doi: 10.1093/jnci/85.5.365
Brédart A, Bottomley A, Blazeby JM, Conroy T, Coens C, D’Haese S et al (2005) An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32). Eur J Cancer 41:2120–2131
pubmed: 16182120 doi: 10.1016/j.ejca.2005.04.041
Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG (2000) Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 56:899–905
pubmed: 11113727 doi: 10.1016/S0090-4295(00)00858-X
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579
pubmed: 8445433 doi: 10.1200/JCO.1993.11.3.570
Botteman MF, Pashos CL, Hauser RS, Laskin BL, Redaelli A (2003) Quality of life aspects of bladder cancer: a review of the literature. Quality Life Res 12:675–688
doi: 10.1023/A:1025144617752
Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M et al (2000) Assessing symptom distress in cancer patients. Cancer 89:1634–1646
pubmed: 11013380 doi: 10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V
Dominique I, Palamara C, Champetier D, Terrier JE, Morel Journel N, Ruffion A et al (2019) Réhabilitation précoce après tumorectomie rénale robot-assistée: quelle satisfaction des patients ? Progrès en Urologie. 29:634–641
pubmed: 31444104 doi: 10.1016/j.purol.2019.07.006
Mason SJ, Downing A, Wright P, Hounsome L, Bottomley SE, Corner J et al (2018) Health-related quality of life after treatment for bladder cancer in England. Br J Cancer 118:1518–1528
pubmed: 29755116 pmcid: 5988662 doi: 10.1038/s41416-018-0084-z
Mason SJ, Catto JWF, Downing A, Bottomley SE, Glaser AW, Wright P (2018) Evaluating patient-reported outcome measures (PROMs) for bladder cancer: a systematic review using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist. BJU Int. 122:760–773
pubmed: 29726085 pmcid: 6221027 doi: 10.1111/bju.14368
Catto JWF, Khetrapal P, Ambler G, Sarpong R, Potyka I, Khan MS et al (2018) Multidomain quantitative recovery following radical cystectomy for patients within the robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy randomised controlled trial: the first 30 patients. Eur Urol 74:531–534
pubmed: 29793815 doi: 10.1016/j.eururo.2018.05.008
Ziegelmueller BK, Jokisch JF, Buchner A, Grimm T, Kretschmer A, Schulz GB, Stief C, Karl A (2020) Long-term follow-up and oncological outcome of patients undergoing radical cystectomy for bladder cancer following an Enhanced Recovery after Surgery (ERAS) protocol: results of a large randomized, prospective. Single-Center Study. Urologia Internationalis. 104(1–2):54–60
Eskicioglu C, Forbes SS, Aarts M-A, Okrainec A, McLeod RS (2009) Enhanced Recovery after Surgery (ERAS) programs for patients having colorectal surgery: a meta-analysis of randomized trials. J Gastrointestinal Surg. 13:2321
doi: 10.1007/s11605-009-0927-2
Li D, Jensen CC (2019) Patient satisfaction and quality of life with enhanced recovery protocols. Clin Colon Rectal Surg 32:138–144
pubmed: 30833864 pmcid: 6395092 doi: 10.1055/s-0038-1676480
Day RW, Cleeland CS, Wang XS, Fielder S, Calhoun J, Conrad C et al (2015) Patient-reported outcomes accurately measure the value of an enhanced recovery program in liver surgery. J Am Coll Surg 221(1023–30):e2
Jones E, Wainwright T, Foster J, Smith J, Middleton R, Francis N (2014) A systematic review of patient reported outcomes and patient experience in enhanced recovery after orthopaedic surgery. Ann R Coll Surg Engl. 96:89–94
pubmed: 24780662 pmcid: 4474266 doi: 10.1308/003588414X13824511649571
Rauwerdink A, Jansen M, De Borgie C, Bemelman W, Daams F, Schijven M et al (2019) Improving enhanced recovery after surgery (ERAS): eRAS APPtimize study protocol, a randomized controlled trial investigating the effect of a patient-centred mobile application on patient participation in colorectal surgery. BMC Surg. 19:125
pubmed: 31477107 pmcid: 6719362 doi: 10.1186/s12893-019-0588-3
Zheng Y, Mao M, Ji M, Zheng Q, Liu L, Zhao Z et al (2020) Does a pulmonary rehabilitation based ERAS program (PREP) affect pulmonary complication incidence, pulmonary function and quality of life after lung cancer surgery? study protocol for a multicenter randomized controlled trial. BMC Pulmonary Med. 20:44
doi: 10.1186/s12890-020-1073-6
Manger JP, Nelson M, Blanchard S, Helo S, Conaway M, Krupski TL (2014) Alvimopan: a cost-effective tool to decrease cystectomy length of stay. Cent Eur J Urol. 67:335–341
doi: 10.5173/ceju.2014.04.art4
Ghodoussipour S, Naser-Tavakolian A, Cameron B, Mitra AP, Miranda G, Cai J et al (2020) Internal audit of an enhanced recovery after surgery protocol for radical cystectomy. World J Urol. https://doi.org/10.1007/s00345-020-03135-w
doi: 10.1007/s00345-020-03135-w pubmed: 32112242
Joliat G-R, Ljungqvist O, Wasylak T, Peters O, Demartines N (2018) Beyond surgery: clinical and economic impact of Enhanced Recovery After Surgery programs. BMC Health Services Res. 18:1008
doi: 10.1186/s12913-018-3824-0
Gentry ZL, Boitano TK, Smith HJ, Eads DK, Russell JF, Straughn JM Jr (2020) The financial impact of an enhanced recovery after surgery (ERAS) protocol in an academic gynecologic oncology practice. Gynecol Oncol 156:284–287
pubmed: 31776038 doi: 10.1016/j.ygyno.2019.11.017
Lee L, Mata J, Ghitulescu GA, Boutros M, Charlebois P, Stein B et al (2015) Cost-effectiveness of Enhanced Recovery Versus Conventional Perioperative Management for Colorectal Surgery. Ann Surg 262:1026–1033
pubmed: 25371130 doi: 10.1097/SLA.0000000000001019
Abola RE, Bennett-Guerrero E, Kent ML, Feldman LS, Fiore JFJ, Shaw AD et al (2018) American Society for enhanced recovery and perioperative quality initiative joint consensus statement on patient-reported outcomes in an enhanced recovery pathway. Anesth Analg 126:1874–1882
pubmed: 29293180 doi: 10.1213/ANE.0000000000002758

Auteurs

Nathan A Brooks (NA)

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Andrea Kokorovic (A)

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

John S McGrath (JS)

Department of Urology, Royal Devon and Exeter NHS Trust, Exeter, UK.

Wassim Kassouf (W)

Department of Urology, McGill University Health Center, McGill, Montreal, QC, Canada.

Justin W Collins (JW)

Department of Urology, University College London Hospital, London, UK.

Peter C Black (PC)

Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.

James Douglas (J)

Department of Urology, University Hospital of Southampton, Hampshire, UK.

Hooman Djaladat (H)

USC Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.

Siamak Daneshmand (S)

USC Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.

James W F Catto (JWF)

Academic Urology Unit, University of Sheffield, Sheffield, UK.

Ashish M Kamat (AM)

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Stephen B Williams (SB)

Division of Urology, The University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA. stbwilli@utmb.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH